LeMaitre Vascular Inc (LMAT)

Return on equity (ROE)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	44,038	30,105	20,636	26,907	21,220
Total stockholders’ equity	US$ in thousands	337,290	297,900	268,201	254,151	172,572
ROE		13.06%	10.11%	7.69%	10.59%	12.30%

December 31, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $44,038K ÷ $337,290K
= 13.06%

The Return on Equity (ROE) of LeMaitre Vascular Inc has shown some fluctuations over the years based on the provided data.

As of December 31, 2020, the ROE stood at 12.30%, indicating that for each dollar of shareholder equity, the company generated a return of 12.30%.

By December 31, 2021, the ROE decreased to 10.59%, suggesting a slight decline in the company's ability to generate profits using its equity.

The ROE further dropped to 7.69% by December 31, 2022, signaling a more significant decrease in the profitability of the company relative to its equity.

However, there was a rebound in the ROE by December 31, 2023, where it rose to 10.11%, showing some improvement in the company's profitability compared to the previous year.

Finally, as of December 31, 2024, the ROE increased to 13.06%, indicating the company's enhanced ability to generate profits using its equity.

Overall, the ROE trend of LeMaitre Vascular Inc reflects fluctuations in the company's profitability relative to its shareholders' equity over the years, with both decreases and increases observed during the period under review. It is essential for stakeholders to monitor these changes to assess the company's performance and financial health.